#stayhome Maintain the distance, wash your hands, and follow instructions from the health authorities.

POST Online Media Lite Edition


ThermoGenesis: J. Melville Engle CEO, Matthew Plavan COO

Staff writer |
Rancho Cordova, Ca., USA - April 14, 2009, Rancho Cordova, Ca., USA - ThermoGenesis Corp. has named J. Melville Engle as Chief Executive Officer, effective April 14.

Mr. Engle has more than 30 years of management experience in the healthcare industry. Engle holds a B.S. in Accounting from the University of Colorado and an M.B.A. in Finance from the University of Southern California. Mr. Engle was most recently Chief Executive Officer of Raydiance, Inc., a laser technology company. For six years, he served as President and Chief Executive Officer of Dey LP, and before that, he was Chairman, President and Chief Executive Officer of Anika Therapeutics, Inc. Mr. Engle also served as Regional Director, North America, for the Merck Generics Group. He was with Allergan, Inc., for 14 years, holding senior management positions that included Chief Financial Officer, Senior Vice President of U.S. Sales and head of the company's operations in Canada and Latin America. He is currently a member of the board of directors of Oxygen Biotherapeutics (OXBO).


What to read next

Arcadia Bio appoints Matthew Plavan as CFO
Skyline Medical appoints two to its board
Anthera Pharmaceuticals announces personnel changes